IFF Looks 35.2% Overvalued on GF Value™ as Dividend Sustainability Faces Challenges
gurufocus.com · 2026-09-17
On September 17, 2026, International Flavors & Fragrances Inc (NYSE: IFF) announced the launch of Omni-Bos PHY, a cutting-edge phytase enzyme designed to improv
TickrTrends take: IFF is currently assessed as overvalued by TickrTrends, and the company's valuation challenges are compounded by questions about the sustainability of its dividend payments. For investors focused on valuation metrics, the combination of elevated pricing relative to intrinsic value and concerns about dividend coverage presents a risk that warrants monitoring of cash flow trends and capital allocation decisions. In the Basic Materials sector, where companies are often valued on their ability to generate reliable cash returns, any deterioration in IFF's financial position could further pressure the stock relative to its current valuation.
Read the full story at gurufocus.com →
Is IFF undervalued? See TickrTrends' fair value analysis →